Iterum Therapeutics plc (ITRM)

NASDAQ: ITRM · IEX Real-Time Price · USD

1.430

-0.010 (-0.69%)

At close: Apr 18, 2024, 3:59 PM

1.480

+0.050 (3.50%)

After-hours: Apr 18, 2024, 7:14 PM EDT

Iterum Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Revenue	0	0	0	0	0.04	0.87	0.51	0
Revenue Growth (YoY)	-	-	-	-	-95.74%	71.06%	-	-
Gross Profit	0	0	0	0	0.04	0.87	0.51	0
Selling, General & Admin	7.48	12.77	13.83	11.05	11.28	8.78	4.46	3.26
Research & Development	39.99	17.62	10.71	21.07	90.77	68.65	25.5	10.1
Operating Expenses	47.47	30.38	24.54	32.13	102.06	77.43	29.96	13.36
Operating Income	-47.47	-30.38	-24.54	-32.13	-102.02	-76.56	-29.46	-13.36
Interest Expense / Income	1.43	2.36	5.55	15.1	0.86	0.43	-0.28	0
Other Expense / Income	-11.14	11.39	60.77	4.04	-0.2	-0.4	-0.22	-0.01
Pretax Income	-37.76	-44.13	-90.86	-51.26	-102.69	-76.58	-28.96	-13.35
Income Tax	0.61	0.3	0.71	0.74	0.44	0.47	0.44	0.11
Net Income	-38.37	-44.43	-91.56	-52.01	-103.13	-77.06	-29.41	-13.46
Shares Outstanding (Basic)	13	12	11	2	1	1	0	0
Shares Outstanding (Diluted)	13	12	11	2	1	1	0	0
Shares Change	5.93%	12.35%	580.42%	65.38%	66.22%	4974.28%	627.19%	-
EPS (Basic)	-2.96	-3.63	-8.41	-32.49	-106.50	-132.30	-2562.60	-8533.05
EPS (Diluted)	-2.96	-3.63	-8.41	-32.49	-106.50	-132.30	-2562.60	-8533.05
Free Cash Flow	-39.34	-18.54	-15.9	-54.54	-81.95	-77.34	-31.42	-11.3
Free Cash Flow Per Share	-3.04	-1.51	-1.46	-34.07	-84.67	-132.83	-2737.70	-7160.30
Gross Margin	-	-	-	-	100.00%	100.00%	100.00%	-
Operating Margin	-	-	-	-	-275732.43%	-8810.01%	-5798.23%	-
Profit Margin	-	-	-	-	-278729.73%	-8867.20%	-5788.58%	-
Free Cash Flow Margin	-	-	-	-	-221475.68%	-8900.12%	-6184.25%	-
EBITDA	-34.58	-39.97	-83.2	-36.01	-101.67	-76.02	-29.17	-13.35
EBITDA Margin	-	-	-	-	-274791.89%	-8748.22%	-5742.91%	-
Depreciation & Amortization	1.75	1.8	2.1	0.16	0.15	0.14	0.07	0
EBIT	-36.33	-41.77	-85.31	-36.17	-101.83	-76.16	-29.24	-13.35
EBIT Margin	-	-	-	-	-275202.70%	-8763.87%	-5755.71%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).